Sudden unexpected death in an adolescent with epilepsy: All roads lead to the heart? by Pinto, Kylvia G. F. D. et al.
CASE REPORT
Cardiology Journal
2011, Vol. 18, No. 2, pp. 194–196
Copyright © 2011 Via Medica
ISSN 1897–5593
194 www.cardiologyjournal.org
â
âAddress for correspondence:  Dr. Vera Cristina Terra, Centro de Cirurgia de Epilepsia, Departamento de Neurociencias
e Ciencias do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Riberão Preto,
São Paulo, Brasil, CEP 14048-900, tel: 55 (16) 3602-2613, fax: 55 (16) 3633-0760, e-mail: v.c.terra@rnp.fmrp.usp.br
Received: 24.10.2009 Accepted: 04.01.2010
â â
Sudden unexpected death in an adolescent
with epilepsy: All roads lead to the heart?
Kylvia G.F.D. Pinto1, Fulvio A. Scorza2, Ricardo M. Arida3, Esper A. Cavalheiro2,
Luciana D. Martins1, Helio R. Machado1, Américo C. Sakamoto1, Vera C. Terra1
1Centro de Cirurgia de Epilepsia (CIREP), Departamento de Neurociencias e Ciencias do Comportamento,
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil
2Disciplina de Neurologia Experimental, Universidade Federal de São Paulo/
/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil
3Departamento de Fisiologia, Universidade Federal de São Paulo/
/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil
Abstract
The incidence of sudden unexpected death in epilepsy (SUDEP) has been estimated from 0.5–
–1.4/1,000 person-years in people with treated epilepsy, and 9/1,000 person-years in candidates
for epilepsy surgery. Potential risk factors for SUDEP include: age, early onset of epilepsy,
duration of epilepsy, uncontrolled seizures, seizure type and winter temperatures. The arrythmogenic
side-effect of antiepileptic drugs and seizures may increase the risk of SUDEP. In this report,
we describe a patient with prolonged post-ictal tachycardia in EEG video recordings with
a typical case of SUDEP: a 16-year-old boy with medically intractable complex partial sei-
zures. Magnetic resonance imaging revealed left mesial temporal sclerosis. During non-inva-
sive video-EEG monitoring, the patient presented a post-ictal heart rate increased for five
hours. Two months after video-EEG, he died from SUDEP during a tonic-clonic secondary
generalized seizure. The possibility of cardiac involvement in the pathogenesis of SUDEP has
been suggested by many studies. Evaluation of this patient with EEG-video monitoring, in-
cluding measurement of heart rate, contributed to an identification of ictal tachycardia that
may have played a role in the SUDEP. Premature mortality seems to be increased in patients
with epilepsy, and cardiac abnormalities may be a possible cause of SUDEP. (Cardiol J 2011;
18, 2: 194–196)
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Introduction
Sudden unexpected death in epilepsy (SUDEP)
is defined as sudden, unexpected, witnessed or
unwitnessed, non-traumatic and non-drowning
deaths in patients with epilepsy, with or without
evidence of a seizure and excluding documented
status epilepticus, in which a post-mortem examina-
tion does not reveal a toxicological or anatomical
cause of death [1]. The incidence of SUDEP has
been estimated from 0.5–1.4/1,000 person-years in
people with treated epilepsy, and 9/1,000 person-
-years in candidates for epilepsy surgery [2]. Poten-
tial risk factors for SUDEP include: age, early on-
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set of epilepsy, duration of epilepsy, uncontrolled
seizures, seizure type and winter temperatures [3, 4].
The potential arrythmogenic side-effect of antiepi-
leptic drugs and seizures has also been suspected
to increase the risk of SUDEP [5]. In this report,
we describe a patient with prolonged post-ictal ta-
chycardia in EEG video recordings who proved to
be a typical SUDEP case.
Case history
A 16 year-old boy with normal neurodevelopment
had had suffering medically intractable epileptic sei-
zures since the age of five. His seizures consisted
of abdominal auras followed by gestural automa-
tisms, with occasional secondary generalization.
Magnetic resonance imaging revealed left mesial
temporal sclerosis. The patient was taking carba-
mazepine (1,200 mg/day), phenobarbital (200 mg/day)
and clobazam (40 mg/day), but was still suffering
from two to three seizures per week.
During non-invasive video-EEG monitoring,
the patient presented three complex partial sei-
zures, with seizure onset characterized by left tem-
poral theta rhythm. One of the seizures was fol-
lowed by a secondarily tonic-clonic generalization.
No abnormalities in electrocardiogram (ECG) were
found. Heart rate (HR) analysis showed a baseline
bradycardia of 42 bpm. One minute after seizure
termination, HR increased to 119 bpm and a tachy-
cardia of 92 bpm persisted for five hours. Eight
hours after the seizure ended, the patient was
asymptomatic and had an HR of 77 bpm (Fig. 1). The
patient was referred to a cardiologist for clinical
investigation. However, two months after the
video-EEG, he died during a tonic-clonic secondary
generalized seizure. The patient was in a good state
of health and a post-mortem examination did not
reveal any cardiac abnormality. The cause of death
was considered as SUDEP.
Discussion
The possibility of cardiac involvement in the
pathogenesis of SUDEP has been suggested by many
studies. For instance, antiepileptic drugs may induce
lengthening of the ECG Q-T interval, combined with
a mild pro-arrhythmic effect of epileptic seizure
discharges, and consequent transient cardiac insta-
bility leading to arrhythmic death [1]. Similarly,
some studies have demonstrated that patients with
frontal lobe epilepsy presented interictally faster
heart rates attributed to lower parasympathetic
drive, which might contribute to the higher incidence
of sudden death [6]. Furthermore, events of ictal
bradycardia or asystole may be very relevant in
epilepsy patients presenting ictal falls and could be
a potential contributor to heart rate variability in
some SUDEP cases. Sympathetic activity increas-
es (while parasympathetic activity decreases) after
seizures, suggesting that SUDEP could be triggered
by cardiac arrhythmias during or immediately after
seizures [2]. Recently, Montepietra et al. [7] report-
ed five patients who developed ischemic ECG
changes following seizures, some of them with post-
ictal supraventricular tachycardia or atrial fibrilla-
tion. This suggests that tachyarrhythmias may con-
Figure 1. A. Normal wake-up EEG showing baseline
heart rate one minute before seizure onset; B. Post-ictal
EEG one minute after seizure end, with a significant
increase of heart rate; C. Late post-ictal EEG (five hours
after seizure end) showing a maintained increase in he-
art rate when compared to baseline.
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tribute to cardiovascular disease in patients with
chronic epilepsy that potentially may lead the pa-
tient to torsades de pointes. Evaluation of this pa-
tient with EEG-video monitoring, including mea-
surement of heart rate, contributed to identify ictal
tachycardia that may have played a role in our
SUDEP case related here.
Overall, premature mortality seems to be in-
creased in patients with epilepsy, particularly in
those with more severe seizures, and it is general-
ly acknowledged that cardiac abnormality is the very
probable cause of SUDEP.
Finally understanding the mechanisms behind
SUDEP will be the  key to prevention. In the mean
time, it seems reasonable to assume that the best
way to minimize the risk of SUDEP is effective
seizure control [8]. Moreover, we believe that the
neurologist should be aware of SUDEP and cardio-
logical investigation should be recommended to
search for abnormalities of HR or ischemic events.
In the same way, strategies such as taking a detailed
cardiovascular history, looking for cardiovascular
disease, symptoms, cardiovascular risk factors and
prior cardiac findings (electrocardiogram and
echocardiogram) should be developed by a cardio-
logist or a general practitioner.
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